[{"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97613", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0006-2026", "product_description": "Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.", "product_quantity": "54,432 bottles", "reason_for_recall": "Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.", "recall_initiation_date": "20250916", "center_classification_date": "20251006", "report_date": "20251015", "code_info": "Lot # D2300045, Exp 12/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["KOFAL"], "generic_name": ["METHYL SALICYLATE"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-109"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["METHYL SALICYLATE"], "rxcui": ["1101920", "2273244"], "spl_id": ["372a9f84-8b6f-7db6-e063-6394a90a7fdd"], "spl_set_id": ["9cac377d-97bc-f0b7-e053-2a95a90a2e12"], "package_ndc": ["55758-109-02"], "is_original_packager": [true], "unii": ["LAV5U5022Y"], "upc": ["899711001013"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0426-2025", "product_description": "KOFAL, Athletes, Penetrating Pain Relief, External Analgesic Ointment (methyl salicylate 10.5% - External Analgesic), 2 oz (60 g) Jar, Distributed by: Pharmadel LLC, New Castle, DE 19720, NDC 55758-109-02, UPC 8 99711 00101 3.", "product_quantity": "11,808 Jars", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP30A, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210698"], "brand_name": ["SUCCINYLCHOLINE"], "generic_name": ["SUCCINYLCHOLINE"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc.,"], "product_ndc": ["43598-666"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["SUCCINYLCHOLINE CHLORIDE"], "rxcui": ["1594589"], "spl_id": ["3e170b7b-58cc-fd7e-a547-7feaae62194a"], "spl_set_id": ["f55dd1c0-c259-219a-5bca-f139e9515d07"], "package_ndc": ["43598-666-11", "43598-666-25"], "is_original_packager": [true], "upc": ["0343598666259", "0343598666112"], "unii": ["I9L0DDD30I"]}, "product_type": "Drugs", "event_id": "97690", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "600 College Rd E Ste 4000", "address_2": "", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0008-2026", "product_description": "Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540.  NDC: 43598-666-25", "product_quantity": "571 vials", "reason_for_recall": "Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.", "recall_initiation_date": "20250926", "center_classification_date": "20251007", "report_date": "20251015", "code_info": "Lot # K250048", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203503"], "brand_name": ["VORICONAZOLE"], "generic_name": ["VORICONAZOLE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-572", "68462-573"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VORICONAZOLE"], "rxcui": ["349434", "349435"], "spl_id": ["1c47b796-6b3e-4321-86f6-f51fbf9a39fb"], "spl_set_id": ["4cbac6ad-0faa-4181-a830-27a9f1536b7a"], "package_ndc": ["68462-572-30", "68462-572-90", "68462-572-13", "68462-573-30", "68462-573-90", "68462-573-13"], "is_original_packager": [true], "upc": ["0368462573303"], "nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["JFU09I87TR"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0318-2025", "product_description": "Voriconazole Tablets 200 mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-573-30", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17230853, exp. date Mar-25 17231271, exp. date May-25 17231300, exp. date May-25 17242050, exp. date Oct-26 17231046, exp. date Apr-25 17241156, exp. date Jun-26 17241388, exp. date Jul-26 17241800, exp. date Sep-26"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217791"], "brand_name": ["ATROPINE SULFATE"], "generic_name": ["ATROPINE SULFATE MONOHYDRATE"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "product_ndc": ["70069-716"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["ATROPINE SULFATE"], "rxcui": ["1190655"], "spl_id": ["07ece291-b401-4c28-9c81-6b686aa36e07"], "spl_set_id": ["bfdb85b2-86d0-4f32-a8fa-272af48a191c"], "package_ndc": ["70069-716-01"], "is_original_packager": [true], "upc": ["0370069716014"], "unii": ["03J5ZE7KA5"]}, "product_type": "Drugs", "event_id": "95997", "recalling_firm": "SOMERSET THERAPEUTICS LLC", "address_1": "300 Franklin Square Dr", "address_2": "", "postal_code": "08873-4187", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0169-2025", "product_description": "Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01", "product_quantity": "5,870 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20241216", "center_classification_date": "20241231", "termination_date": "20250610", "report_date": "20250108", "code_info": "Lot #: A240211, Exp. Date April 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212294"], "brand_name": ["TAVABOROLE"], "generic_name": ["TAVABOROLE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-102"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TAVABOROLE"], "rxcui": ["1543177"], "spl_id": ["266f7bbc-b540-4681-8144-cbb823f34f0e"], "spl_set_id": ["c13610c8-c57a-4519-b37d-eb4fbdcec398"], "package_ndc": ["72578-102-04"], "is_original_packager": [true], "nui": ["N0000191279", "N0000000150", "M0002832"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "pharm_class_cs": ["Boron Compounds [CS]"], "unii": ["K124A4EUQ3"]}, "product_type": "Drugs", "event_id": "97424", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "N/A", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0595-2025", "product_description": "Tavaborole Topical Solution 5%, 10 mL per glass bottle, Rx Only, For Topical Use Only, Manufactured by: Zydus Lifesciences Ltd., Changodar Ahmedabad, India.  Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016.  NDC:  72578-102-04", "product_quantity": "3960  bottles", "reason_for_recall": "Discoloration", "recall_initiation_date": "20250812", "center_classification_date": "20250821", "report_date": "20250827", "code_info": "Lot #: T401968"}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0556-2025", "product_description": "Tirzepatide + Niacinamide  6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "160 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Rahway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204569"], "brand_name": ["BELSOMRA"], "generic_name": ["SUVOREXANT"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "product_ndc": ["0006-0005", "0006-0033", "0006-0325", "0006-0335"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUVOREXANT"], "rxcui": ["1547104", "1547110", "1547112", "1547114", "1547116", "1547118", "1547573", "1547575"], "spl_id": ["21306af5-e07a-4f8e-8f59-3e0aacc53102"], "spl_set_id": ["e5b72731-1acb-45b7-9c13-290ad12d3951"], "package_ndc": ["0006-0005-10", "0006-0005-30", "0006-0005-13", "0006-0033-10", "0006-0033-30", "0006-0033-13", "0006-0325-10", "0006-0325-30", "0006-0325-13", "0006-0335-10", "0006-0335-30", "0006-0335-13"], "is_original_packager": [true], "nui": ["N0000191000", "N0000190998", "N0000185503", "N0000190114"], "pharm_class_epc": ["Orexin Receptor Antagonist [EPC]"], "pharm_class_moa": ["Orexin Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]"], "unii": ["081L192FO9"]}, "product_type": "Drugs", "event_id": "97254", "recalling_firm": "Merck & Co. Inc", "address_1": "126 E Lincoln Ave", "address_2": "N/A", "postal_code": "07065-4607", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA and PR.", "recall_number": "D-0584-2025", "product_description": "Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway, NJ 07065, USA, NDC 0006-0033-10 (Shellpack and Print Mat Labels), 0006-0033-30 (Carton Label)", "product_quantity": "51,320 cartons", "reason_for_recall": "Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.", "recall_initiation_date": "20250721", "center_classification_date": "20250813", "report_date": "20250820", "code_info": "Lots 2090019 and 2123744, Exp. 4/30/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212144"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-861", "68462-862", "68462-863", "68462-864", "68462-865"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["440a4208-83cc-4ffa-952c-d9c0745c342a"], "spl_set_id": ["a6065ac5-a111-449b-b51b-8bc2907d1ddb"], "package_ndc": ["68462-861-01", "68462-861-10", "68462-862-01", "68462-862-10", "68462-863-01", "68462-863-10", "68462-864-01", "68462-864-10", "68462-865-01", "68462-865-10"], "is_original_packager": [true], "upc": ["0368462862018", "0368462864012", "0368462863015", "0368462861011"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "95658", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0309-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01", "product_quantity": "8160 bottles", "reason_for_recall": "CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.", "recall_initiation_date": "20250311", "center_classification_date": "20250402", "report_date": "20250409", "code_info": "Lot#s: 17232222 and 17232237, Exp 10/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091346"], "brand_name": ["VIORELE"], "generic_name": ["DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-318"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["248310", "249357", "748797", "759743", "1252016"], "spl_id": ["34bbda2e-5e46-488d-9b7d-09081112ceaa"], "spl_set_id": ["39988aa6-8f68-40e8-9bdd-c40a3bdaad61"], "package_ndc": ["68462-318-29"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "97547", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0021-2026", "product_description": "Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Blisters each containing 28 Tablets, Rx only, 28 day Regimen, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA., Mahwah, NJ, 07430, NDC 68462-318-29.", "product_quantity": "26,928 packs", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250903", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Batch number 20230733, Exp Date: October 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Racine", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96324", "recalling_firm": "Johnson, S C and Son, Inc", "address_1": "1525 Howe St", "address_2": "", "postal_code": "53403-2237", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States and Canada", "recall_number": "D-0275-2025", "product_description": "Kids by babyganics SPF 50 totally tropical (titanium dioxide 3/5%, zinc oxide 7.25%) packaged in a) 6 OZ (170 g) spray bottles UPC 813277019954 and UPC 813277019800; and b) Twinpack UPC 813277019930; Dist. by KAS Direct LLC, 1525 Howe St. Racine, WI 53403.", "product_quantity": "449,502 units", "reason_for_recall": "Chemical Contamination", "recall_initiation_date": "20250213", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "a) UPC 813277019954  Lot #: A034 / 5810343A, A034 / 5820343A, Exp. Date Feb-25; A282 / 0122853A,  A289 / 0132853A, Exp. Date Oct-25; C010 / 1680174A, C011 / 1690174A, Exp. Date Jan-26;  C218 / 2592224A, C218 / 2602224A, Exp. Date Aug-26.  UPC 813277019800 Lot #: A142 / 3901443A, A142 / 3911443A, A142 / 3921443A, Exp. Date May-25; A278 / 0142843A, A279 / 0152843A, A279 / 0162843A, Exp. Date Oct-25; A314 / 4473263A, A314 / 4483263A, A317 / 4493263A, Exp. Date Nov-25; C046 / 0100594A, C047 / 0110594A C050 / 0120594A, Exp. Date Feb-26; C068 / 2770774A, C071 / 2790774A, Exp. Date Mar-26;  C102 / 9621154A, C102 / 9621154B, C102 / 9621154C, Exp. Date Apr-26; C144 / 4721534A,  C144 / 4731534A, C144 / 4741534A, C144 / 4751534A, Exp. Date May-26  b) UPC 813277019930 Lot #: A033 / 5830343A, Exp. Date Feb-25; A079 / 9620893A, A079 / 9630893A, Exp. Date Mar-25; A142 / 3881453A, A142 / 3891453A, Exp. Date May-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96607", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "N/A", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0372-2025", "product_description": "PHENYLephrine HCl in 0.9% Sodium Chloride, 0.5 mg per 5mL (100 mcg/mL), 5 mL Single Dose Syringe, Rx Only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-001-11,", "product_quantity": "7,290 syringes", "reason_for_recall": "Lack of Assurance of Sterility: Leaking/damaged syringes.", "recall_initiation_date": "20250331", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot #: 2431349A, Exp.: 6/16/2025"}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0565-2025", "product_description": "Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "158 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Cardinal Health 107, LLC", "Major Pharmaceuticals"], "product_ndc": ["55154-7895", "0904-2725"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198335"], "spl_id": ["18413c21-00e0-4267-9db2-7295bf3dd0df", "b9b2bafa-6f1d-4874-a864-d2878d4c87a2"], "spl_set_id": ["5dc03027-cdaf-461f-87fd-630d382fc723", "abe0d2d5-4879-4b4e-9b57-47ea83a17ba0"], "package_ndc": ["55154-7895-0", "0904-2725-61"], "original_packager_product_ndc": ["0904-2725", "65162-272"], "upc": ["0055154789509"], "nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["JE42381TNV", "AN164J8Y0X"]}, "product_type": "Drugs", "event_id": "97523", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0625-2025", "product_description": "Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1) per bag, Rx only, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-7895-0 (Outer Bag) containing NDC 0904-2725-61 (Inner blisters).", "product_quantity": "N/A", "reason_for_recall": "Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250902", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Bag: N02309A and N02309B, Exp Date: 03/31/2027; Inner blister: Lot # N02309, Exp Date: 03/31/2027"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078251"], "brand_name": ["CARVEDILOL"], "generic_name": ["CARVEDILOL"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7305", "0904-7306", "0904-7307", "0904-7308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARVEDILOL"], "rxcui": ["200031", "200032", "200033", "686924"], "spl_id": ["f6fe7bf0-2539-4a5f-aef1-d8b0516b4b75"], "spl_set_id": ["ec6d8d73-9d18-4a9e-ae0c-0ea12059e78e"], "package_ndc": ["0904-7305-61", "0904-7306-61", "0904-7307-61", "0904-7308-61"], "original_packager_product_ndc": ["68462-162", "68462-163", "68462-164", "68462-165"], "nui": ["N0000000099", "N0000009923", "N0000009924", "N0000175553", "N0000175556"], "pharm_class_moa": ["Adrenergic alpha-Antagonists [MoA]", "Adrenergic beta1-Antagonists [MoA]", "Adrenergic beta2-Antagonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Blocker [EPC]", "beta-Adrenergic Blocker [EPC]"], "unii": ["0K47UL67F2"]}, "product_type": "Drugs", "event_id": "97449", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States.", "recall_number": "D-0594-2025", "product_description": "Carvedilol Tablets USP, 12.5 mg, 100- Tablets, (10x10) cartons, Rx Only, Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN, 46268, USA, NDC 0904-7307-61", "product_quantity": "26,628 cartons", "reason_for_recall": "CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm", "recall_initiation_date": "20250820", "center_classification_date": "20250821", "report_date": "20250827", "code_info": "Lot #: T05693, Exp. Date 03/2026"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-047", "16714-048", "16714-049", "16714-050", "16714-051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["13fe8f97-37e8-4d10-87fe-e1d17f4f23d8"], "spl_set_id": ["2bd42d3a-bf89-4d74-a252-9b914106a570"], "package_ndc": ["16714-047-01", "16714-048-01", "16714-049-01", "16714-050-01", "16714-051-01"], "is_original_packager": [true], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0631-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141.  NDC:  16714-047-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot#: Z403011, Exp Date 30-04-26; Z407335, Exp Date 30-11-26"}, {"status": "Ongoing", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["38f67256-77a9-0598-e063-6294a90a9d2d"], "spl_set_id": ["85291b2b-40b9-07fa-e053-2a91aa0a84e4"], "package_ndc": ["54365-400-31"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "96262", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-0259-2025", "product_description": "BD ChloraPrep Clear 1mL Applicators, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile Solution, 0.03 fl. oz (1 mL) each, 60 Applicators per Carton, CareFusion 213, LLC, El Paso, TX 79912, Subsidiary of Becton, Dickinson and Co., REF 930480, NDC 54365-400-31.", "product_quantity": "205,440 applicators", "reason_for_recall": "Non-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.", "recall_initiation_date": "20250214", "center_classification_date": "20250307", "report_date": "20250319", "code_info": "Lot #: 3200240, Exp 6/30/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Chantilly", "state": "VA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA217027"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Granules Pharmaceuticals Inc."], "product_ndc": ["70010-029", "70010-030", "70010-031", "70010-032", "70010-033", "70010-034"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["40cbcbf0-8e41-789e-e063-6294a90ab711"], "spl_set_id": ["8c672e06-0778-4a7d-b398-5bcbf2a73f12"], "package_ndc": ["70010-029-01", "70010-030-01", "70010-031-01", "70010-032-01", "70010-033-01", "70010-034-01"], "is_original_packager": [true], "upc": ["0370010029019", "0370010030015", "0370010032019", "0370010034013", "0370010031012", "0370010033016"], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97504", "recalling_firm": "Granules Pharmaceuticals Inc.", "address_1": "3701 Concorde Pkwy", "address_2": "N/A", "postal_code": "20151-1126", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0673-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 30 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-034-01", "product_quantity": "11,928 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:", "recall_initiation_date": "20250828", "center_classification_date": "20250924", "report_date": "20251001", "code_info": "Lot#: GPC250181A, Exp Date: 06-19-2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96744", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Distributed to Medical Facilities in MS and FL.", "recall_number": "D-0400-2025", "product_description": "Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01", "product_quantity": "3", "reason_for_recall": "Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025.   The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.", "recall_initiation_date": "20250425", "center_classification_date": "20250501", "report_date": "20250507", "code_info": "Lot #: 1MP24042, Exp 6/30/26", "more_code_info": ""}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96666", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide US.", "recall_number": "D-0394-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-447-17", "product_quantity": "4,888 Bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20250410", "center_classification_date": "20250430", "report_date": "20250507", "code_info": "Lot # D2300323, Exp Date: 01/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0557-2025", "product_description": "Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol,  Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "139 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0483-2025", "product_description": "Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "826 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot #BH11235 exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; BH11235 , exp 5/5/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; BH272962 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; BH272962 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; BH00048 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX11212024 , exp 5/20/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRX12825-2 , exp 7/27/2025 ; PRO30625-2 , exp 9/2/2025 ; PRO30625-2 , exp 9/2/2025 ; PRO30625-2 , exp 9/2/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; PRX012825-2 , exp 9/27/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; AB11212024 , exp 11/21/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ; BH66-1002 , exp 12/30/2025 ;", "more_code_info": ""}, {"status": "Ongoing", "city": "Conshohocken", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97329", "recalling_firm": "IMMUNOCORE, LLC", "address_1": "Six Tower Bridge", "address_2": "181 Washington St Ste 540", "postal_code": "19428-2068", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "US Nationwide", "recall_number": "D-0614-2025", "product_description": "KIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, Single-Does vial. Mfd by: Immunocore Limited, 92 Park Drive, Abingdon, Oxfordshire, OX14 4RY, United Kingdom, For: Immunocore Commercial LLC, 181 Washington St, Conshohocken, PA, 19428, Product of Denmark   NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026   NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026", "product_quantity": "7,572 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250610", "center_classification_date": "20250903", "report_date": "20250910", "code_info": "NDC 80446-0401-01 Lot #: 3D009AA09, 3D009AA10, 3D009AA25, Exp Date: 31 MAR 2026   NDC 80446-0401-99 (Non-Commercial FG) Lot #: 3D009AA02, Exp Date 31 MAR 2026"}, {"status": "Ongoing", "city": "Mumbai", "state": "", "country": "India", "classification": "Class III", "openfda": {"application_number": ["ANDA211417"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-393", "33342-394", "33342-395", "33342-396", "33342-397", "33342-398", "33342-399", "33342-400", "33342-401", "33342-402", "33342-403", "33342-404"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["3a77ca51-7d8a-4755-aabc-3801cc772a10"], "spl_set_id": ["b8c20f76-3ee6-4b29-b77f-ed4ad1baaed9"], "package_ndc": ["33342-393-10", "33342-393-11", "33342-393-44", "33342-394-10", "33342-394-11", "33342-394-44", "33342-395-10", "33342-395-11", "33342-395-44", "33342-396-10", "33342-396-11", "33342-396-44", "33342-397-10", "33342-397-11", "33342-397-44", "33342-398-10", "33342-398-11", "33342-398-44", "33342-399-10", "33342-399-11", "33342-399-44", "33342-400-10", "33342-400-11", "33342-400-44", "33342-401-10", "33342-401-11", "33342-401-44", "33342-402-10", "33342-402-11", "33342-402-44", "33342-403-10", "33342-403-11", "33342-403-44", "33342-404-10", "33342-404-11", "33342-404-44"], "is_original_packager": [true], "upc": ["0333342393104", "0333342397102", "0333342404107", "0333342393111", "0333342400109", "0333342403100", "0333342393449", "0333342394101", "0333342402103", "0333342396105", "0333342395108", "0333342398109", "0333342399106"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96979", "recalling_firm": "Macleods Pharmaceuticals Ltd", "address_1": "304 Atlanta Arcade", "address_2": "Church Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0470-2025", "product_description": "Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.", "product_quantity": "1,344- 1000 count bottles", "reason_for_recall": "Presence of a foreign substance: black hair found embedded in tablet.", "recall_initiation_date": "20250529", "center_classification_date": "20250612", "report_date": "20250618", "code_info": "Lot #: MLF2401A, Exp 01/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Taizhou", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97344", "recalling_firm": "Taizhou Kangping Medical Science And Technology Co., Ltd.", "address_1": "Hailing Industrial Park", "address_2": "27 Tai'An Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0589-2025", "product_description": "BZK Antiseptic Towelette, Sterile, For External Use Only, benzalkonium chloride 0.13%, Antiseptic, 100 towelettes per carton , For Professional use, Mfg by: Taizhou Kangping Medical, Taizhou, JiangSu, China, NDC: 71310-111-01", "product_quantity": "3.85 million Cartons", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20250722", "center_classification_date": "20250818", "report_date": "20250827", "code_info": "Lot Numbers: 220583459, 230553459, 232743459, 110523, 031524, 052224, 247793459"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96742", "recalling_firm": "Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)", "address_1": "88 Inverness Cir E Unit A204", "address_2": "", "postal_code": "80112-5521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "USA Nationwide", "recall_number": "D-0487-2025", "product_description": "Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112", "product_quantity": "16 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250521", "center_classification_date": "20250620", "report_date": "20250702", "code_info": "Lot: GA37484", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090778"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["57237-017", "57237-018", "57237-019"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934"], "spl_id": ["4166006e-ead3-4e01-8b11-07d26ac957ed"], "spl_set_id": ["ea2dc1a6-22d5-4295-9d39-9bf015dc5a89"], "package_ndc": ["57237-017-60", "57237-017-99", "57237-018-30", "57237-018-90", "57237-018-99", "57237-019-30", "57237-019-90", "57237-019-99"], "is_original_packager": [true], "upc": ["0357237018309", "0357237017609", "0357237019306"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96427", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "N/A", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0277-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99", "product_quantity": "1223 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.", "recall_initiation_date": "20250305", "center_classification_date": "20250314", "report_date": "20250326", "code_info": "Lot #: DTB23111A, Exp 8/31/2025"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209239"], "brand_name": ["SOLIFENACIN SUCCINATE"], "generic_name": ["SOLIFENACIN SUCCINATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-386", "68462-387"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SOLIFENACIN SUCCINATE"], "rxcui": ["477367", "477372"], "spl_id": ["9cfcab1d-64ac-457b-979f-41cf6547a63a"], "spl_set_id": ["010c0657-c907-477f-8bd7-5d455a5f50eb"], "package_ndc": ["68462-386-30", "68462-386-90", "68462-386-14", "68462-387-30", "68462-387-90", "68462-387-14"], "is_original_packager": [true], "upc": ["0368462386309", "0368462387306"], "unii": ["KKA5DLD701"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0317-2025", "product_description": "Solifenacin Succinate Tablets 10MG, a. 30-count bottle (NDC# 68462-387-30),  b. 90-Count Bottle (NDC 68462-387-90),Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # 17230762, exp. date Mar-25"}, {"status": "Ongoing", "city": "Medchal Malkajgiri", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96209", "recalling_firm": "Aspen Biopharma Labs Pvt., Ltd.", "address_1": "Plot No 10, Biotech Park Phase-II", "address_2": "Lalgadi Malakpet Village,Turkapally, Shameerpet Mandal", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)", "recall_number": "D-0265-2025", "product_description": "Voriconazole Container Description: voriconazole\tThe product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.", "product_quantity": "4.0 kg", "reason_for_recall": "CGMP violations", "recall_initiation_date": "20250207", "center_classification_date": "20250309", "report_date": "20250319", "code_info": "Lot Number: HAVZC0020922, exp. date AUG-2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Yangzhou", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97278", "recalling_firm": "YANGZHOU YULOU PAPER PRODUCTS CO., LTD", "address_1": "No. 888 Jinbao West Road", "address_2": "Baoying County", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "N/A", "recall_number": "D-0659-2025", "product_description": "Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%), 100 Sterile Pads per carton, AUM Pharmaceuticals, 320 Oser Ave., Hauppauge, NY 11788.", "product_quantity": "500 cases", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20250721", "center_classification_date": "20250923", "report_date": "20251001", "code_info": "Lot #: 20240610, Exp. Date 06/2029", "more_code_info": ""}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA103976"], "brand_name": ["XOLAIR"], "generic_name": ["OMALIZUMAB"], "manufacturer_name": ["Genentech, Inc."], "product_ndc": ["50242-040", "50242-214", "50242-215", "50242-227"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["OMALIZUMAB"], "rxcui": ["1657209", "1657212", "2058943", "2058946", "2058949", "2058950", "2663917", "2663918", "2663920", "2663923", "2673760", "2673761", "2673762", "2673763"], "spl_id": ["0c18e533-1b61-4224-9e5c-05cd1eb86f2b"], "spl_set_id": ["7f6a2191-adfb-48b9-9bfa-0d9920479f0d"], "package_ndc": ["50242-040-62", "50242-040-86", "50242-214-01", "50242-214-86", "50242-214-03", "50242-214-55", "50242-214-99", "50242-214-83", "50242-215-86", "50242-215-01", "50242-215-03", "50242-215-55", "50242-215-99", "50242-215-83", "50242-227-01", "50242-227-55", "50242-227-99", "50242-227-86"], "is_original_packager": [true], "nui": ["N0000175794", "N0000175793", "N0000175792"], "pharm_class_epc": ["Anti-IgE [EPC]"], "pharm_class_pe": ["Decreased IgE Activity [PE]"], "pharm_class_moa": ["IgE-directed Antibody Interactions [MoA]"], "unii": ["2P471X1Z11"]}, "product_type": "Drugs", "event_id": "97360", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide Within the U.S.", "recall_number": "D-0571-2025", "product_description": "Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 50242-215-55.", "product_quantity": "6 units", "reason_for_recall": "CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.", "recall_initiation_date": "20250730", "center_classification_date": "20250807", "report_date": "20250813", "code_info": "Lot: 3617756, Expires: 12/31/2025.", "more_code_info": ""}, {"status": "Ongoing", "city": "Seymour", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215565"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["Lannett Company, Inc."], "product_ndc": ["0527-0760", "0527-0761", "0527-0762", "0527-0763", "0527-0764", "0527-0765", "0527-0766"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["541363", "541878", "541892", "577957", "577961", "687043", "1009145"], "spl_id": ["e0804f43-4685-4017-b839-3212d1167362"], "spl_set_id": ["f92497b5-baea-4760-b615-45a0b6184402"], "package_ndc": ["0527-0760-37", "0527-0761-37", "0527-0762-37", "0527-0763-37", "0527-0764-37", "0527-0765-37", "0527-0766-37"], "is_original_packager": [true], "unii": ["JJ768O327N", "6DPV8NK46S", "G83415V073", "O1ZPV620O4"]}, "product_type": "Drugs", "event_id": "97461", "recalling_firm": "Lannett Company Inc.", "address_1": "1101 C Ave W", "address_2": "N/A", "postal_code": "47274-3342", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0642-2025", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100 Tablets per bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-0762-37.", "product_quantity": "4,848 bottles", "reason_for_recall": "Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.", "recall_initiation_date": "20250819", "center_classification_date": "20250911", "report_date": "20250917", "code_info": "Lot#: 25283185A. Expiry: 02/28/2027"}, {"status": "Ongoing", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019635"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-7800", "0264-7802"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807633", "1807634", "1807639"], "spl_id": ["9fa9f6b4-63b5-4632-8104-37c3dd1ee8fa"], "spl_set_id": ["7f22c06b-6b4d-4b49-a4b2-d2169f2bd653"], "package_ndc": ["0264-7800-00", "0264-7800-10", "0264-7800-20", "0264-7802-00", "0264-7802-10"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "97059", "recalling_firm": "B BRAUN MEDICAL INC", "address_1": "861 Marcon Blvd", "address_2": "", "postal_code": "18109-9577", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0491-2025", "product_description": "0.9% Sodium Chloride Injection USP, 500 mL, packaged in 500 mL excel containers and further packaged 24 per case, Rx only, B.Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC 0264-7800-10.", "product_quantity": "187,656 containers", "reason_for_recall": "Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.", "recall_initiation_date": "20250616", "center_classification_date": "20250624", "report_date": "20250702", "code_info": "Lot #: J4L260, J4L261, J4L270, J4L271, J4L280, Exp 2/28/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Chestnut Ridge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209226"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-883", "64380-884", "64380-885"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["61399d7c-ee88-4df1-b3b3-b4995e787a53"], "spl_set_id": ["0ba47b6a-ba49-4d7a-82e1-1c6e49bfa5d7"], "package_ndc": ["64380-883-04", "64380-884-04", "64380-885-04"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "97215", "recalling_firm": "Strides Pharma, Inc.", "address_1": "1 Ram Ridge Rd", "address_2": "", "postal_code": "10977-6714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0546-2025", "product_description": "Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, India; Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-885-04", "product_quantity": "6,672 bottles", "reason_for_recall": "Failed Dissolution Specifications.", "recall_initiation_date": "20250709", "center_classification_date": "20250730", "report_date": "20250806", "code_info": "Lot #: 7715893A, Exp. Date 12/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Easton", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M019"], "brand_name": ["POWER STICK ORIGINAL NOURISHING INVISIBLE PROTECTION ROLL- ON ANTIPERSPIRANT DEODORANT"], "generic_name": ["ALUMINUM SESQUICHLOROHYDRATE"], "manufacturer_name": ["A.P. Deauville, LLC"], "product_ndc": ["42913-040"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALUMINUM SESQUICHLOROHYDRATE"], "spl_id": ["1d4815b7-2be6-ae41-e063-6294a90a3a87"], "spl_set_id": ["24935b2d-d4c0-4965-b928-c648ceea6fb4"], "package_ndc": ["42913-040-00", "8151950182"], "is_original_packager": [true], "upc": ["0815195018224", "815195018224"], "unii": ["UCN889409V"]}, "product_type": "Drugs", "event_id": "97211", "recalling_firm": "A.P. Deauville, LLC", "address_1": "3700 Glover Rd", "address_2": "N/A", "postal_code": "18040-9285", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0550-2025", "product_description": "Shave and Skincare Power Stick Original Nourishing Invisible Protection Roll-On Antiperspirant/Deodorant, 1.8 oz./ 53 mL,  A.P Deauville, LLC, PA 18040, NDC# 42913-040-00 UPC Code 815195018224", "product_quantity": "23,467 Cases", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250710", "center_classification_date": "20250731", "report_date": "20250723", "code_info": "Lot #  101225D781, 032926B281, 032826B221, 041126B531, 062226D011, 070626D301, 070626D333, 111026G051, 111326G091, 111626G221"}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0559-2025", "product_description": "Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "143 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203269"], "brand_name": ["RIZATRIPTAN BENZOATE"], "generic_name": ["RIZATRIPTAN BENZOATE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-261", "67877-262"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIZATRIPTAN BENZOATE"], "rxcui": ["312840", "314209"], "spl_id": ["9fd3ccaa-ae93-475b-9591-5c4af70f51c5"], "spl_set_id": ["07e66554-bc85-4853-9f40-1249617630a9"], "package_ndc": ["67877-261-30", "67877-261-01", "67877-261-05", "67877-261-18", "67877-261-25", "67877-262-30", "67877-262-01", "67877-262-05", "67877-262-18", "67877-262-25"], "is_original_packager": [true], "upc": ["0367877261300"], "unii": ["WR978S7QHH"]}, "product_type": "Drugs", "event_id": "96770", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "N/A", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide.", "recall_number": "D-0533-2025", "product_description": "Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ 07054, NDC 67877-261-18", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.", "recall_initiation_date": "20250709", "center_classification_date": "20250717", "report_date": "20250723", "code_info": "Lot 23142117, 23142119, 23142122, Exp Date: May 2026; Lot 24142625, Exp Date: Jun. 2027"}, {"status": "Ongoing", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96446", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0297-2025", "product_description": "fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1259-75", "product_quantity": "1,765 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20250306", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot, expiry:  Lot 10140303, exp 04/14/2025; Lots 10140867, 10140868, exp 04/24/2025; Lot  10140965, exp 04/28/2025"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["CINNAFRESH"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-133"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["f40c6912-d01e-4193-b969-5f568775fabf"], "spl_set_id": ["0296448d-bde7-45f5-9972-1963cba70f4f"], "package_ndc": ["53247-133-01"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0430-2025", "product_description": "Cinnafresh anticavity gel toothpaste, sodium fluoride 0.22%, Bold Cinnamon Flavor, NET WT. 0.85 OZ (24 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-133-01", "product_quantity": "383,904 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0011, B0012, Exp Date: 05/31/2026; Lot B0070, B0074, Exp Date: 08/31/2026; Lot B0075, B0077, B0078, B0079, B0080, B0081, B0082, B0083, B0084, B0085, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020832"], "brand_name": ["CHLORAPREP ONE-STEP"], "generic_name": ["CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL"], "manufacturer_name": ["CareFusion 213, LLC"], "product_ndc": ["54365-400"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE", "ISOPROPYL ALCOHOL"], "rxcui": ["858726", "998282"], "spl_id": ["38f67256-77a9-0598-e063-6294a90a9d2d"], "spl_set_id": ["85291b2b-40b9-07fa-e053-2a91aa0a84e4"], "package_ndc": ["54365-400-31"], "is_original_packager": [true], "unii": ["MOR84MUD8E", "ND2M416302"]}, "product_type": "Drugs", "event_id": "96879", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0441-2025", "product_description": "BD ChloraPrep Clear, 2% x/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile Solution, Applicator is sterile if package is intact, Flammable, External Use Only, 1 mL Applicator per pouch, 60 Applicators per inner carton, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., Made in the USA, Catalog Number 930480, NDC 54365-400-31.", "product_quantity": "385,200 applicators", "reason_for_recall": "Lack of Assurance of Sterility: The affected product may exhibit an open seal on the packaging of the applicator.", "recall_initiation_date": "20250515", "center_classification_date": "20250520", "report_date": "20250528", "code_info": "Lot #s: 3354127 and 3350974, Exp Date: 12/31/2026"}, {"status": "Ongoing", "city": "Malvern", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA207934"], "brand_name": ["EVEROLIMUS"], "generic_name": ["EVEROLIMUS"], "manufacturer_name": ["ENDO USA, Inc."], "product_ndc": ["49884-119", "49884-125", "49884-127", "49884-128"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EVEROLIMUS"], "rxcui": ["845507", "845515", "998189", "1119400"], "spl_id": ["d82ae1c1-347f-44cb-a0bd-56d0fe4d267f"], "spl_set_id": ["45d54974-3fc4-4237-a2fa-3158ca1a8105"], "package_ndc": ["49884-119-52", "49884-119-91", "49884-125-52", "49884-125-91", "49884-127-52", "49884-127-91", "49884-128-52", "49884-128-91"], "is_original_packager": [true], "nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "unii": ["9HW64Q8G6G"]}, "product_type": "Drugs", "event_id": "97557", "recalling_firm": "Endo USA, Inc.", "address_1": "9 Great Valley Pkwy", "address_2": "", "postal_code": "19355-1304", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0026-2026", "product_description": "Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91", "product_quantity": "1,041 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.", "recall_initiation_date": "20250905", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot #: 550172301, Exp. Date January 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Prescott", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97652", "recalling_firm": "SV Labs Prescott Corporation", "address_1": "1115 Dexter St N", "address_2": "", "postal_code": "54021-1768", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0022-2026", "product_description": "Aloe Up Sport Performance Sunscreen Lotion SPF 30, 1 FL OZ (30 mL) per tube, Mfd. for: ALOE UP, 9700 W. 76th St., Ste 112, Eden Prairie, Minnesota 55344", "product_quantity": "11,386 tubes", "reason_for_recall": "cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.", "recall_initiation_date": "20250925", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot#: 25196, Exp 2/16/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-2725"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198335"], "spl_id": ["b9b2bafa-6f1d-4874-a864-d2878d4c87a2"], "spl_set_id": ["abe0d2d5-4879-4b4e-9b57-47ea83a17ba0"], "package_ndc": ["0904-2725-61"], "original_packager_product_ndc": ["65162-272"], "nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["JE42381TNV", "AN164J8Y0X"]}, "product_type": "Drugs", "event_id": "97523", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0624-2025", "product_description": "Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets  unit dose blister packs (10x10) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-2725-61", "product_quantity": "N/A", "reason_for_recall": "Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250902", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot # N02309, Exp 03/31/2027"}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Northwind Pharmaceuticals, LLC"], "product_ndc": ["51655-307"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198335"], "spl_id": ["1d154f8c-549d-4ecb-e063-6294a90a05bb"], "spl_set_id": ["f2b8e9d9-1274-22ca-e053-2a95a90a6f1a"], "package_ndc": ["51655-307-20", "51655-307-29", "51655-307-53", "51655-307-84", "51655-307-87"], "original_packager_product_ndc": ["65162-272"], "nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["JE42381TNV", "AN164J8Y0X"]}, "product_type": "Drugs", "event_id": "97544", "recalling_firm": "Northwind Pharmaceuticals LLC", "address_1": "4838 Fletcher Ave Ste 1000", "address_2": "N/A", "postal_code": "46203-1642", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0654-2025", "product_description": "Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count bottles (NDC 51655-307-87), b) 10-count bottles (NDC 51655-307-53), c) 14-count bottles (NDC 51655-307-84), d) 20-count bottles (NDC 51655-307-20) Rx Only, Repackaged from Amneal Pharmaceuticals LLC. Repackaged by: Northwind Pharmaceuticals, Indianapolis, IN 46203.", "product_quantity": "a) 96 bottles, b) 627 bottles, c) 428 bottles, d) 1144 bottles", "reason_for_recall": "Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.", "recall_initiation_date": "20250820", "center_classification_date": "20250917", "report_date": "20250924", "code_info": "Lot #: a) F118062503, Exp Date 05/31/2027, F118062507, Exp Date. 07/31/2027. b) F118062504, F118062505, Exp. Date 05/31/2027; F118062509, Exp. Date. 08/31/2027; F118062512, Exp. Date 04/30/2027. c) F118062506, Exp. Date 06/30/2027. d) F118062423, Exp. Date 01/31/2027; F118062501, Exp. Date 06/30/2027; F118062502, Exp. Date 04/30/2027; F118062508, Exp. Date 08/31/2027."}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215037"], "brand_name": ["NELARABINE"], "generic_name": ["NELARABINE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["70710-1726"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NELARABINE"], "rxcui": ["603566"], "spl_id": ["b3627acf-0207-443a-8e5a-0b4ad974715a"], "spl_set_id": ["e425731e-626b-4141-a997-fb85e077c2a4"], "package_ndc": ["70710-1726-1", "70710-1726-8"], "is_original_packager": [true], "upc": ["0370710172619"], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["60158CV180"]}, "product_type": "Drugs", "event_id": "96291", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0255-2025", "product_description": "Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1726-1;  b) 6 x 50 mL Single-Dose Vial, NDC 70710-1726-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ", "product_quantity": "36,978 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250213", "center_classification_date": "20250306", "report_date": "20250312", "code_info": "Lot: a) P300072, P300073 Exp. Feb-2025; P300153, Exp. Jun-25; P300195, Exp. Aug-2025; P400014, P400017, Exp. Dec-2025; P400070, Exp. Feb-2026; P400112, May-2026; P400142, Exp. Jul-2026; b) P300068, Exp. Feb-2025; P300154, Exp.Jun-2025; P400015, P400018, Exp. Dec-2025; P400068, Exp. Feb-2026; P400114, Exp. May-2026; P400139, Exp.Jul-2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0241-2025", "product_description": "Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-758-01.", "product_quantity": "233,040 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19232540, 19232524, 19232553, Exp.: 5/2025; 19240510, Exp.: 1/2026; 19241489, Exp.: 3/2026; 19243905, 19243935, Exp.: 9/2026."}, {"status": "Ongoing", "city": "Historic New Castle", "state": "DE", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["RAPIDOL ARNICA"], "generic_name": ["ARNICA MONTANA"], "manufacturer_name": ["Pharmadel LLC"], "product_ndc": ["55758-405"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ARNICA MONTANA"], "spl_id": ["2734f895-0036-187d-e063-6394a90a20f6"], "spl_set_id": ["051ec8dc-02cf-e8f7-e063-6294a90a378e"], "package_ndc": ["55758-405-99"], "is_original_packager": [true], "unii": ["O80TY208ZW"]}, "product_type": "Drugs", "event_id": "96639", "recalling_firm": "Pharmadel, LLC", "address_1": "650 Centerpoint Blvd", "address_2": "N/A", "postal_code": "19720-8108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "DE", "recall_number": "D-0383-2025", "product_description": "Rapidol Arnica Tablets, Homeopathic Medicine, 100-count bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-405-99", "product_quantity": "6,048 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250415", "center_classification_date": "20250421", "report_date": "20250430", "code_info": "Lot, expiry: EAT-01, EXP: MAR 27"}, {"status": "Ongoing", "city": "Kennett Square", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97202", "recalling_firm": "Boothwyn Pharmacy LLC", "address_1": "221 Gale Ln", "address_2": "N/A", "postal_code": "19348", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0609-2025", "product_description": "Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy", "product_quantity": "648 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20250709", "center_classification_date": "20250829", "report_date": "20250910", "code_info": "03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025"}, {"status": "Ongoing", "city": "Memphis", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200770"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["McKesson Corporation dba SKY Packaging"], "product_ndc": ["63739-327"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905225"], "spl_id": ["29ba565b-f079-8375-e063-6394a90a83be"], "spl_set_id": ["b9117e55-9fd0-4ba2-94b4-f5f8c522d70c"], "package_ndc": ["63739-327-10", "0000127312", "0000127576", "0000127577", "0000128204", "0000128358"], "original_packager_product_ndc": ["64380-734"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "96159", "recalling_firm": "SKY PACKAGING", "address_1": "4835 Crumpler Rd Ste B", "address_2": "", "postal_code": "38141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0219-2025", "product_description": "HydrALAZINE Hydrochloride, 25 mg, 100 Unit Dose Tablets (10x10), USP, Rx only, Manufactured by Strides Pharma Science Ltd, Bengaluru, India, Distributed by McKesson by: McKesson Corporation dba SKY Packaging, TN 38141. NDC 63739-327-10", "product_quantity": "", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20250124", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot #: 0000127312, Exp. Date 31-Mar-2025; 0000127576, 0000127577, Exp. Date 31-Jul-2025; 0000128204, Exp. Date 31-Dec-2025; 0000128358, Exp. Date 31-Jan-2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96853", "recalling_firm": "KABANA SKIN CARE", "address_1": "685 S Arthur Ave Unit 9b", "address_2": "N/A", "postal_code": "80027-3141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, FL, MI", "recall_number": "D-0515-2025", "product_description": "In Your Face Mineral Tint SPF 31, Zinc Oxide 25%, Tinted Sunscreen Broad Spectrum UVA & UVB chemical free, Organic Ingredients, Biodegradable & Baby Safe, 50 mL - 1.7 fl oz per bottle, Manufactured for IN YOUR FACE Skin Care, Belleair Bluffs, FL, Made in USA, NDC: 73369-1601-1", "product_quantity": "76 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250312", "center_classification_date": "20250710", "report_date": "20250716", "code_info": "Lot: 408-002", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209663"], "brand_name": ["TERIFLUNOMIDE"], "generic_name": ["TERIFLUNOMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-423", "68462-424"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TERIFLUNOMIDE"], "rxcui": ["1310525", "1310533"], "spl_id": ["2b8615da-20b8-47dd-afe4-fb494392c118"], "spl_set_id": ["cb431ea0-ba0f-4b5d-a50d-f8c050762242"], "package_ndc": ["68462-423-15", "68462-423-85", "68462-423-30", "68462-424-15", "68462-424-85", "68462-424-30"], "is_original_packager": [true], "upc": ["0368462423301", "0368462424308"], "nui": ["N0000185502", "N0000185501"], "pharm_class_epc": ["Pyrimidine Synthesis Inhibitor [EPC]"], "pharm_class_moa": ["Dihydroorotate Dehydrogenase Inhibitors [MoA]"], "unii": ["1C058IKG3B"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0334-2025", "product_description": "Teriflunomide Tablets, 14mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-424-30", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232462, exp. date Nov-25"}, {"status": "Ongoing", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214019"], "brand_name": ["DAPSONE"], "generic_name": ["DAPSONE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DAPSONE"], "rxcui": ["1741905"], "spl_id": ["fbed711e-945e-46aa-8883-fee0b7604485"], "spl_set_id": ["30867c69-cf3c-4360-8e56-db96e0b0c3ab"], "package_ndc": ["72578-094-01", "72578-094-02", "72578-094-03"], "is_original_packager": [true], "nui": ["N0000175881", "M0020791"], "pharm_class_epc": ["Sulfone [EPC]"], "pharm_class_cs": ["Sulfones [CS]"], "unii": ["8W5C518302"]}, "product_type": "Drugs", "event_id": "95930", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0171-2025", "product_description": "Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.  packaged in an Airless pump pack", "product_quantity": "23304 packs", "reason_for_recall": "Crystallization", "recall_initiation_date": "20241210", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA216350"], "brand_name": ["FLUPHENAZINE HYDROCHLORIDE"], "generic_name": ["FLUPHENAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-336", "68462-914", "68462-337", "68462-338"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUPHENAZINE HYDROCHLORIDE"], "rxcui": ["859841", "860918", "865117", "865123"], "spl_id": ["a0534178-2ffc-4beb-adf2-00a2f2d246c4"], "spl_set_id": ["4c3eea71-a7a1-4eda-9871-034ddeb83ed6"], "package_ndc": ["68462-914-01", "68462-914-05", "68462-914-14", "68462-336-01", "68462-336-05", "68462-336-14", "68462-337-01", "68462-337-05", "68462-337-14", "68462-338-01", "68462-338-05", "68462-338-14"], "is_original_packager": [true], "upc": ["0368462338018", "0368462337011", "0368462914144"], "unii": ["ZOU145W1XL"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0327-2025", "product_description": "Fluphenazine Hydrochloride Tablets 2.5mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-336-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17232214, exp. date Sep-25"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95953", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0158-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08", "product_quantity": "1,815 bottles", "reason_for_recall": "CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lots, expiry: Lot DT6022166A, exp 11/30/2024; Lot DT6023071A, exp 2/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Chestnut Ridge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076744"], "brand_name": ["TESTOSTERONE"], "generic_name": ["TESTOSTERONE"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-151", "64380-152"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["TESTOSTERONE"], "rxcui": ["1597123", "1597129"], "spl_id": ["6d50f17e-4607-458a-882b-620daa3b58a9"], "spl_set_id": ["ee54c393-bcfe-4a52-b7b3-1da8750f35d9"], "package_ndc": ["64380-152-01", "64380-152-02", "64380-151-01", "64380-151-02"], "is_original_packager": [true], "upc": ["0364380151012", "0364380152019"], "nui": ["N0000175824", "N0000000146", "M0001109"], "pharm_class_epc": ["Androgen [EPC]"], "pharm_class_moa": ["Androgen Receptor Agonists [MoA]"], "pharm_class_cs": ["Androstanes [CS]"], "unii": ["3XMK78S47O"]}, "product_type": "Drugs", "event_id": "96412", "recalling_firm": "Strides Pharma, Inc.", "address_1": "1 Ram Ridge Rd", "address_2": "N/A", "postal_code": "10977-6714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S", "recall_number": "D-0293-2025", "product_description": "Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton,  Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-151-02", "product_quantity": "195,952 Cartons; 30 sachets/Carton.", "reason_for_recall": "Presence of foreign substance: Presence of Benzene.", "recall_initiation_date": "20250305", "center_classification_date": "20250325", "report_date": "20250402", "code_info": "Lot #: 5501127A, 5501236A, Exp Apr-25; 5501341A, Exp Jun-25; 5501406A, Exp Jul-25; 5501408A, Exp Aug-25; 5501516A, Exp Sep-25; 5501568A, Exp Oct-25; 5501829A, Exp Mar-26; 5502000A, Exp Jul-26; 5502004A, 5502005A, Exp Aug-26; 5502092A, Exp Oct-26; 5502217A, Exp Dec-26; 5502262A, Exp Jan-27"}, {"status": "Ongoing", "city": "Aurangabad, Maharashtra State", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077259"], "brand_name": ["TIMOLOL MALEATE"], "generic_name": ["TIMOLOL MALEATE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["64980-513", "64980-514"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL MALEATE"], "rxcui": ["1923428", "1992303"], "spl_id": ["7ef88352-6fe4-48a4-b72b-15419d3ed051"], "spl_set_id": ["2ed21930-1e05-46de-8acd-cb6f4798a7fa"], "package_ndc": ["64980-513-05", "64980-513-01", "64980-513-15", "64980-514-05", "64980-514-01", "64980-514-15"], "is_original_packager": [true], "upc": ["0364980513050", "0364980514057"], "unii": ["P8Y54F701R"]}, "product_type": "Drugs", "event_id": "96196", "recalling_firm": "FDC Limited", "address_1": "B-8 MIDC Industrial Area", "address_2": "Waluj District", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to one (1) Us Distributor in NJ", "recall_number": "D-0214-2025", "product_description": "Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.", "product_quantity": "118104 bottles", "reason_for_recall": "Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.", "recall_initiation_date": "20250123", "center_classification_date": "20250131", "report_date": "20250212", "code_info": "Lot#: 083J033, Exp. Date 09/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0422-2025", "product_description": "CURA HONGOS, Antifungal, 1% Clotrimazole, Topical Lotion, 0.76 fl oz (22.5 mL) Bottle, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-34-01, UPC 8 10096 77170 4.", "product_quantity": "10,128 Bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot SP31A, Exp Date: 09/30/2026"}, {"status": "Ongoing", "city": "Lakewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96792", "recalling_firm": "BSO LLC", "address_1": "12860 W Cedar Dr Ste 211", "address_2": "N/A", "postal_code": "80228-1971", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0413-2025", "product_description": "TESTOSTERONE PELLET 200 mg (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0125-01", "product_quantity": "1,974 vials", "reason_for_recall": "Presence of Particulate Matter: Glass particles were found in pellet vials.", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot 20250207@1, exp 1/31/2026; Lot 20250228@1, exp 1/31/2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA208699"], "brand_name": ["EZETIMIBE AND SIMVASTATIN"], "generic_name": ["EZETIMIBE AND SIMVASTATIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-321", "68462-322", "68462-323", "68462-324"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EZETIMIBE", "SIMVASTATIN"], "rxcui": ["476345", "476349", "476350", "476351"], "spl_id": ["9c80244b-f111-425c-bf4c-c8cc91300cce"], "spl_set_id": ["32d0e130-1211-44ca-be60-5379ffec96fd"], "package_ndc": ["68462-321-90", "68462-321-10", "68462-321-30", "68462-322-30", "68462-322-90", "68462-322-10", "68462-323-30", "68462-323-90", "68462-323-05", "68462-324-30", "68462-324-90", "68462-324-05"], "is_original_packager": [true], "upc": ["0368462321300", "0368462322307", "0368462323304"], "nui": ["N0000175589", "N0000000121", "N0000008553", "N0000175911"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["AGG2FN16EV", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "96884", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and PR", "recall_number": "D-0462-2025", "product_description": "Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90", "product_quantity": "6,759 Con - 90 bottle pack", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.", "recall_initiation_date": "20250519", "center_classification_date": "20250610", "report_date": "20250618", "code_info": "Lot #: 17240195, Exp 01/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M018"], "brand_name": ["POLYVINYL ALCOHOL"], "generic_name": ["POLYVINYL ALCOHOL"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-678"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYVINYL ALCOHOL"], "rxcui": ["142004"], "spl_id": ["334b3c0f-7061-b4b8-e063-6394a90aee9a"], "spl_set_id": ["f18b61da-4033-341a-e053-2a95a90a8ebf"], "package_ndc": ["50268-678-15"], "is_original_packager": [true], "unii": ["532B59J990"]}, "product_type": "Drugs", "event_id": "96032", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0176-2025", "product_description": "Polyvinyl Alcohol Ophthalmic Solution 1.4%, Moisturizing Lubricant Eye Drops, 0.5 FL OZ (15 mL) bottles, Distributed by AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-678-15", "product_quantity": "0", "reason_for_recall": "LABELING: LABEL MIX-UP", "recall_initiation_date": "20241218", "center_classification_date": "20250102", "report_date": "20250108", "code_info": "Lot #: 0160, Exp. Date April 26 2026", "more_code_info": ""}, {"status": "Ongoing", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97251", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0568-2025", "product_description": "Duloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b) 60-count bottle, NDC 61919-0482-60, c) 90-count bottle, NDC 61919-0482-90;   Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037,", "product_quantity": "875 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250307", "center_classification_date": "20250804", "report_date": "20250813", "code_info": "Lot #:  a) 15AU2420, 01JY2407, 04OC2411, Exp 01/31/2027; 12SE2418, 24OC2424, 20NO2416, Exp 03/31/2027; 21AU2313, 21JY2311, 05JY2313, Exp Date 01/31/2026 b) 13OC2310, 05SE2304, 04AU2306, 21JY2317, 12JY2306, Exp 01/31/2026; 11JY2416, 28JU2414, 19AU2412, 02AU2409, Exp 01/31/2027; 11SE2416, 24OC2425, Exp 03/31/2027;  c) 23AU2317, 21AU2314, Exp 01/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96627", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-0378-2025", "product_description": "Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.  NDC;  70518-3772-00", "product_quantity": "1,858 30-count blister cards", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250324", "center_classification_date": "20250418", "report_date": "20250430", "code_info": "Lot J0826722-121624 Exp. 12/31/2025 Lot J0820365-111324 Exp. 11/30/2025 Lot J0814691-101624 Exp. 10/31/2025"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0521-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-451-17", "product_quantity": "9,739 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300092, Exp Date: 12/31/2025; Lot #D2400722, Exp Date: 03/31/2026"}, {"status": "Ongoing", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090858"], "brand_name": ["GABAPENTIN"], "generic_name": ["GABAPENTIN"], "manufacturer_name": ["Cardinal Health 107, LLC"], "product_ndc": ["55154-3363", "55154-7992", "55154-7993"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GABAPENTIN"], "rxcui": ["310430", "310431", "310432"], "spl_id": ["c5f4a9a6-33bb-4e3a-a8ac-ca41e8355b40"], "spl_set_id": ["41844c21-9e2a-4332-a8ff-9b71ae9032b0"], "package_ndc": ["55154-3363-0", "55154-7992-0", "55154-7993-0"], "original_packager_product_ndc": ["0904-6665", "0904-6666", "0904-6667"], "upc": ["0055154799300", "0055154799201", "0055154336307"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["6CW7F3G59X"]}, "product_type": "Drugs", "event_id": "97087", "recalling_firm": "The Harvard Drug Group LLC", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0508-2025", "product_description": "Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-3363-0", "product_quantity": "3,527 bags", "reason_for_recall": "Defective container; blister packaging inadequately sealed.", "recall_initiation_date": "20250619", "center_classification_date": "20250703", "report_date": "20250709", "code_info": "Lot# M05205A and M05205B, Exp Date 10/2026.", "more_code_info": ""}]